| 1 |
Nagaishi K, Arimura Y, Fujimiya M. Stem cell therapy for inflammatory bowel disease[J]. J Gastroenterol, 2015, 50(3): 280-286.
|
| 2 |
Flores AI, Gómez-Gómez GJ, Masedo-Gonzálezá, e al.Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy？[J]. World J Stem Cells, 2015, 7(2): 343-351.
|
| 3 |
Duran NE, Hommes DW.Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls[J]. Ther Adv Gastroenterol, 2016, 9(4)533-547.
|
| 4 |
Dave M, Papadakis KA, Faubion WA Jr.Immunology of inflammatory bowel disease and molecular targets for biologics[J]. Gastroenterol Clin North Am, 2014, 43(3): 405-424.
|
| 5 |
Hommes D, Colombel JF, Emery P, et al.Changing Crohn′s disease management: Need for new goals and indices to prevent disability and improve quality of life [J]. Am J Gastroenterol, 2010, 105(2): 289-297.
|
| 6 |
Billioud V, Ford AC, Tedesco ED, et al.Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta analysis[J]. Crohns Colitis, 2013, 7(11): 853-867.
|
| 7 |
Dalal J, Gandy K, Domen J. Role of mesenchymal stem cell therapy in Crohn′s disease[J]. Pediatr Res, 2012, 71(4 Pt 2): 445-451.
|
| 8 |
Panaccione R, Ghosh S, Middleton S, et al.Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis[J]. Gastroenterology, 2014, 146(2): 392-400.e3.
|
| 9 |
Thomas A, Lodhia N. Advanced therapy for inflammatory bowel disease: a guide for the primary care physician[J]. J Am Board Fam Med, 2014, 27(3): 411-420.
|
| 10 |
Peyrin-Biroulet L, Loftus EVJ, Colombel JF, Sandborn WJ.The natural history of adult Crohn′s disease in population-based cohorts[J]. Am J Gastroenterol, 2010, 105(2): 289-297.
|
| 11 |
D′Haens G, Baert F, van Assche G et al.Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn′s disease: An open randomised trial[J]. Lancet, 2008, 371(9613): 660-667.
|
| 12 |
Burisch J, Jess T, Martinato M, Lakatos PL.ECCO-EpiCom: The burden of inflammatory bowel disease in Europe[J]. J Crohns Colitis, 2013, 7(4): 322-337.
|
| 13 |
Bernstein CN, Loftus EV Jr, Ng SC, et al.Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease(IOIBD): Hospitalisations and surgery in Crohn′s disease[J]. Gut, 2012, 61(4): 622-629.
|
| 14 |
Chatu S, Saxena S, Subramanian V, et al.The impact of timing and duration of thiopurine treatment on first intestinal resection in Crohn′s disease: national UK population-based study 1989-2010[J]. Am J Gastroenterol, 2014, 109(3): 409-416.
|
| 15 |
Zand A, Van Deen W, Inserra E, et al.Presenteeism in inflammatory bowel diseases: a hidden problem with significant economic impact[J]. Inflamm Bowel Dis, 2015, 21(7): 1623-1630.
|
| 16 |
Armstrong L, Lako M, Buckley N, et al.Editorial: our top 10 developments in stem cell biology over the last 30 years[J]. Stem Cells, 2012, 30(1): 2-9.
|
| 17 |
Shroff G. Human Embryonic Stem Cell Therapy in Crohn′s Disease: A Case Report[J]. Am J Case Rep, 2016, 17(2): 124-128.
|
| 18 |
Okamoto R, Watanabe M. Investigating cell therapy for inflammatory bowel disease[J]. Expert Opin Biol Ther, 2016, 16(8): 1015-1023.
|
| 19 |
Hawkey CJ.Stem cells as treatment in inflammatory bowel disease[J]. Dig Dis, 2012；30(suppl 3): 134-139.
|
| 20 |
Shaker A, Rubin DC.Stem cells: One step closer to gut repair[J]. Nature, 2012, 485(7397): 181-182.
|
| 21 |
Tyndall A, Gratwohl A. Adult stem cell transplantation in autoimmune disease[J]. Curr Opin Hematol, 2009, 16(4): 285-291.
|
| 22 |
Caplan AI, Dennis JE.Mesenchymal Stem Cells as Trophic Mediators[J]. J Cell Biochem, 2006, 98(5): 1076-1084.
|
| 23 |
Caplan AI.Why are MSCs therapeutic? New data: new insight[J]. J Pathol, 2009, 217(2): 318-324.
|
| 24 |
Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system[J]. Nat Rev Immunol, 2012, 12(5): 383-396.
|
| 25 |
Raffaghello L, Bianchi G, Bertolotto M, et al.Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche[J]. Stem Cells, 2008, 26(1): 151-162.
|
| 26 |
Benvenuto F, Ferrari S, Gerdoni E, et al.Human mesenchymal stem cells promote survival of T cells in a quiescent state[J]. Stem Cells, 2007, 25(7): 1753-1760.
|
| 27 |
汪维伟，徐艳华，姜蓉，等．骨髓间充质干细胞移植治疗大鼠溃疡性结肠炎[J]．中国组织工程研究，2012，16(32): 6030-6036.
|
| 28 |
Manieri NA, Mack MR, Himmelrich MD, et al.Mucosally transplanted mesenchymal stem cells stimulate intestinal healing by promoting angiogenesis[J]. J Clin Invest, 2015, 125(9): 3606-3618.
|
| 29 |
Ciccocioppo R, Bernardo ME, Sgarella A, et al.Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn′s disease[J]. Gut, 2011, 60(6): 788-798.
|
| 30 |
Grégoire C, Lechanteur C, Briquet A, et al.Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases[J]. Aliment Pharmacol Ther, 2017, 45(2): 205-221.
|
| 31 |
杨波，赵振林，樊强．自体骨髓间充质干细胞治疗溃疡性结肠炎疗效分析[J]．临床医药实践，2015，24(7): 493-497.
|
| 32 |
Duijvestein M, Vos ACW, Roelofs H, et al.Autologous bone marrowderived mesenchymal stromal cell treatment for refractory luminal Crohn′s disease: results of a phase I study[J]. Gut, 2010, 59(12): 1662-1669.
|
| 33 |
Forbes GM, Sturm MJ, Leong RW, et al.A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn′s disease refractory to biologic therapy[J]. Clin Gastroenterol Hepatol, 2014 12(1): 64-71.
|
| 34 |
Algeri M, Conforti A, Pitisci A, et al.Mesenchymal stromal cells and chronic inflammatory bowel disease[J]. Immunol Lett, 2015, 168(2): 191-200.
|
| 35 |
Lalu MM, McIntyre L, Pugliese C, et al.Safety of cell therapy with mesenchymal stromal cells(SafeCell): a systematic review and meta-analysis of clinical trials[J]. PLoS One, 2012, 7(10): e47559.
|
| 36 |
Guadalajara H, Herreros D, De-La-Quintana P, et al.Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas[J]. Int J Colorectal Dis, 2012, 27(5): 595-600.
|
| 37 |
Hawkey CJ, Snowden JA, Lobo A, et al.Stem cell transplantation for inflammatory bowel disease: practical and ethical issues[J]. Gut, 2000, 46(6): 869-872.
|
| 38 |
Almeida-Porada G, Soland M, Boura J, et al.Regenerative medicine: prospects for the treatment of inflammatory bowel disease[J]. Regen Med, 2013, 8(5): 631-644.
|
| 39 |
Duricova D. What Can We Learn from Epidemiological Studies in Inflammatory Bowel Disease？[J]. Dig Dis, 2017 35(1/2): 69-73.
|
| 40 |
Munir H, McGettrick HM.Mesenchymal Stem Cell Therapy for Autoimmune Disease: Risks and Rewards[J]. Stem Cells Dev, 2015, 24(18): 2091-100.
|